CRO & Vendor Selection Client Impact Projects
Learn more here about our client impact projects in CRO & Vendor Selection services for biotech and biopharma companies worldwide
Avillion, a late-phase therapeutic project partner accelerating market availability, required guidance for CRO selection across two clinical trials. With ambitious delivery timelines and multiple suppliers involved, Avillion needed both robust vendor selection and a governance framework to manage multiple CROs effectively.
A high-potential biotech, entering Phase 2 with an ambitious formulation study, faced late-stage strategic changes that rendered its original CRO unsuitable. Operating with a lean team and under competitive pressures, the sponsor required rapid CRO transition, complete vendor oversight, and embedded operational expertise to stay on schedule and protect data integrity.
Anaveon, a clinical-stage biotech backed by €140M+ in funding, was preparing to advance its lead immunotherapy asset into its first-in-human (FIH) trial. Despite a strong scientific foundation and recent Series A success, the internal team had limited operational experience and minimal exposure to CRO selection. With timelines tightening and strategic visibility increasing, the stakes were high: the right outsourcing decisions could set the tone for their clinical and investor trajectories.
We can help you